• Info
  • Insider Ownership

Insider Trading & Ownership of Jon P. Stonehouse

Location
Birmingham, AL
Summary
The estimated net worth of Jon P. Stonehouse is at least $12,907,595 dollars as of 03 Mar 2026. Jon P. Stonehouse is the Director of BIOCRYST PHARMACEUTICALS INC and owns shares of BIOCRYST PHARMACEUTICALS INC (BCRX) stock worth about $11.96M. Jon P. Stonehouse is the Director of Metsera, Inc. and owns shares of Metsera, Inc. stock worth about $945.5K.
Signature
/s/ Alane P. Barnes, by power of attorney
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Jon P. Stonehouse and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Jon P. Stonehouse has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $12,907,595.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: BIOCRYST PHARMACEUTICALS INC ($11,962,064).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Jon P. Stonehouse

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BCRX BIOCRYST PHARMACEUTICALS INC Director $11,962,064 27 Feb 2026
MTSR Metsera, Inc. Director $945,531 13 Nov 2025
BLCM BELLICUM PHARMACEUTICALS, INC Director 03 Jan 2023

Insider Transactions Reported by Jon P. Stonehouse:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored